Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Apr 2011 11:45

RNS Number : 0118F
LiDCO Group Plc
15 April 2011
 



 

 

 

 

 

Press Release

15 April 2011

 

 

LIDCO GROUP PLC

 

("LiDCO" or the "Company")

 

NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Lidco Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 NO

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 NO

An event changing the breakdown of voting rights

NO

Other (please specify):

 NO

3. Full name of person(s) subject to thenotification obligation: iii

Ingalls & Snyder LLC ("I&S") and Ingalls & Snyder Value Partners LP ("ISVP").

4. Full name of shareholder(s)  (if different from 3.):iv

I&S, on behalf of its clients, has dispositive authority over (i.e. the power and authorization to sell at I&S's discretion) 24,424,368 shares. In respect of 13,820,000 of such 24,424,368 shares ISVP (as beneficial owner) shares dispositive authority with I&S and has voting authority. So in respect of the 13,820,000 shares beneficially held by ISVP, I&S has and ISVP share dispositive authority and ISVP has voting authority.

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

April 13, 2011

6. Date on which issuer notified:

April 14, 2011

7. Threshold(s) that is/are crossed orreached: vi, vii

Interest in excess of 14% of issued share capital.

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 0.5 pence ISIN GB0030546849

23,855,746

-

24,424,368

See note 4 above. I&S has dispositive authority over 24,424,368 shares and ISVP has voting authority and shares dispositive authority in respect of 13,820,000 of such shares.

-

14.04% (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

-

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

24,424,368 (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

14.04% (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Frank Stolba

15. Contact telephone number:

(001) (212) 269 - 7814

 

 

- Ends -

 

 

For further information, please contact:

LiDCO Group Plc

Terry O'Brien (CEO)

Tel: +44 (0)20 7749 1500

Paul Clifford (Finance Director)

Theresa Wallis (Chairman)

www.lidco.com

 

FinnCap

Geoff Nash / Henrik Persson

Stephen Norcross (broking)

Tel: +44 (0)20 7600 1658

www.finncap.com

 

Media enquiries:

Abchurch

Adam Michael / Joanne Shears /

Simone Elviss / Claire Dickinson

Tel: +44 (0) 20 7398 7728

simone.elviss@abchurch-group.com

www.abchurch-group.com

 

About LiDCO Group Plc

LiDCO is a supplier of minimally invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the measurement, analysis, audit, training and sharing of real-time and historic hemodynamic data, in both critical care units and the operating theatre. 

 

Scientific evidence is increasingly linking the optimisation of patients' hemodynamic status with better outcomes and reduced hospital stays and LiDCO's computer-based technology, developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.

 

Key Products:

LiDCOplus: a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%)

LiDCOrapid: a cardiac output monitor designed specifically for use in the operating theatre for fluid and drug management. The monitor enables anesthetists to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being before, during and after surgery. The LiDCOrapid provides:

·;

early and rapid warning of hemodynamic change to aid choice of therapeutic route: fluid or drug

·;

quantification of hemodynamic response,

·;

guidance on effective delivery of fluids to ensure the right amount at the right time

LiDCOview: an easy-to-use graphical display of historical LiDCOplus and LiDCOrapid hemodynamic data.

 

All LiDCO monitors use single-patient disposables (sensors or smartcards) which provide an ongoing revenue stream.

 

Clinical Validation & Education

LiDCO has been selected as the sole technology for two ongoing multi-centre government-funded studies in the UK and US. OPTIMISE is sponsored by the UK Government for optimising cardiovascular management in high-risk abdominal surgery patients and in the US, MOnIToR is a US Government sponsored transplantation donor organ optimisation study. The Company has also developed a hemodynamic workshop at St George's Hospital, London.

 

LiDCO Distribution Network:

LiDCO products are sold through Covidien's sales force in the US. LiDCO's strategy is to sell directly to hospitals in the UK, and through a network of specialty critical care and anesthesia distributors in the rest of the world.

 

LiDCO's sales office is in Cambridge, its manufacturing facility and headquarters are in London and its shares are traded on AIM. For more information please see www.lidco.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBGGDSLXBBGBU
Date   Source Headline
30th Dec 20209:35 amRNSHolding(s) in Company
22nd Dec 20202:26 pmRNSCommencement of Compulsory Purchase
16th Dec 20203:58 pmRNSDirector/PDMR Shareholding
10th Dec 20206:11 pmRNSDirector/PDMR Shareholdings
8th Dec 20206:02 pmRNSNotice of Cancellation
8th Dec 20205:30 pmRNSLiDCO Group
8th Dec 20207:00 amRNSOffer declared unconditional in all respects
7th Dec 202010:57 amRNSForm 8.5 (EPT/RI)
4th Dec 202010:12 amRNSForm 8.5 (EPT/RI)
3rd Dec 202012:02 pmRNSForm 8.5 (EPT/RI)
3rd Dec 20209:17 amRNSForm 8.3 - LiDCO Group Plc
2nd Dec 202012:01 pmRNSForm 8.5 (EPT/RI)
2nd Dec 20208:40 amRNSForm 8.3 - LiDCO Group Plc
1st Dec 202010:43 amRNSForm 8.5 (EPT/RI)
30th Nov 202011:58 amRNSForm 8.5 (EPT/RI)
27th Nov 202010:01 amRNSForm 8.5 (EPT/RI)
26th Nov 202012:20 pmRNSBlock Listing Update
26th Nov 202011:58 amRNSForm 8.5 (EPT/RI)
25th Nov 20203:33 pmRNSForm 8.3 - LiDCO Group Plc
25th Nov 20201:05 pmRNSHolding(s) in Company
25th Nov 20209:09 amRNSForm 8.5 (EPT/RI)
25th Nov 20208:50 amRNSForm 8.3 - [LIDCO GROUP PLC]
25th Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
25th Nov 20207:00 amRNSForm 8.3 - Lidco Group PLC
24th Nov 202010:01 amRNSForm 8.5 (EPT/RI)
24th Nov 20207:00 amRNSFirst closing and extension of Offer
23rd Nov 20205:40 pmRNSForm 8.3 - LiDCO Group Plc
23rd Nov 20204:53 pmRNSHolding(s) in Company
23rd Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
19th Nov 202011:44 amRNSForm 8.5 (EPT/RI)
19th Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
18th Nov 202010:08 amRNSForm 8.5 (EPT/RI)
17th Nov 20206:33 pmRNSForm 8.3 - LIDCO PLC GROUP
17th Nov 20204:50 pmRNSForm 8.3 - LiDCO Group Plc
17th Nov 20202:10 pmRNSForm 8.3 - LiDCO Group Plc
17th Nov 202011:36 amRNSForm 8.5 (EPT/RI)
17th Nov 202010:54 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
17th Nov 20208:56 amRNSForm 8.3 - LIDCO GROUP PLC
16th Nov 20206:36 pmRNSForm 8.3 - LIDCO GROUP
16th Nov 20205:07 pmRNSForm 8 (OPD) LIDCO GROUP PLC
16th Nov 202010:33 amRNSForm 8.5 (EPT/RI)
16th Nov 20207:33 amRNSForm 8.3 - [LIDCO GROUP PLC]
13th Nov 20204:36 pmRNSForm 8.3 - LiDCO Group Plc
13th Nov 20204:00 pmRNSForm 8.3 - LiDCO Group Plc
13th Nov 202011:10 amRNSForm 8.5 (EPT/RI)
12th Nov 202011:28 amRNSForm 8.5 (EPT/RI)
12th Nov 20208:53 amRNSForm 8.3 - LIDCO Group Plc
12th Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
11th Nov 202011:36 amRNSForm 8.5 (EPT/RI)
10th Nov 202011:35 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.